Target
Tyrosine-protein kinase ITK/TSK [357-620,Y512E]
Ligand
BDBM213215
Substrate
n/a
Meas. Tech.
LanthaScreen Kinase Binding Assay
IC50
3.2e+2±0 nM
Citation
 Harling, JDDeakin, AMCampos, SGrimley, RChaudry, LNye, CPolyakova, OBessant, CMBarton, NSomers, DBarrett, JGraves, RHHanns, LKerr, WJSolari, R Discovery of novel irreversible inhibitors of interleukin (IL)-2-inducible tyrosine kinase (Itk) by targeting cysteine 442 in the ATP pocket. J Biol Chem 288:28195-206 (2013) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase ITK/TSK [357-620,Y512E]
Synonyms:
EMT | ITK | ITK_HUMAN | Interlukin-2-inducible tyrosine kinase (Itk) | LYK
Type:
Enzyme
Mol. Mass.:
30027.99
Organism:
Homo sapiens (Human)
Description:
Human Itk truncation (357-620 aa) with Y512E mutation
Residue:
264
Sequence:
VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQETSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL
  
Inhibitor
Name:
BDBM213215
Synonyms:
N-(cis-2-{[4-(4-Morpholinylmethyl)-6-([1,3]thiazolo[5,4-b]pyridin-2-ylamino)-2-pyrimidinyl]amino}cyclohexyl)-2-propenamide (4)
Type:
Small organic molecule
Emp. Form.:
C24H30N8O2S
Mol. Mass.:
494.612
SMILES:
C=CC(=O)N[C@H]1CCCC[C@H]1Nc1nc(CN2CCOCC2)cc(Nc2nc3cccnc3s2)n1 |r|
Structure:
Search PDB for entries with ligand similarity: